Dr. Harvey Berman
Pharmacology And Toxicology
204 Sherman Hall
Buffalo NY, 14214
Phone: 645-2859
Email: hberman@buffalo.edu

View map


EDUCATION

1974 Ph.D., Chemistry
University of Massachusetts
1966 Bachelor of Science, Chemistry
Brooklyn College of CUNY


PUBLICATIONS

Wong L, Radic Z, Brüggemann RJ, Hosea N, Berman HA, Taylor P; Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis.; Biochemistry; 2000 May; 39(19); 5750-5757
Taylor P, Wong L, Radic Z, Tsigelny I, Brüggemann R, Hosea NA, Berman HA; Analysis of cholinesterase inactivation and reactivation by systematic structural modification and enantiomeric selectivity.; Chem Biol Interact; 1999 May; 119-1; 3-15
Luo ZD, Berman HA; The influence of Pb2+ on expression of acetylcholinesterase and the acetylcholine receptor.; Toxicol Appl Pharmacol; 1997 Aug; 145(2); 237-245
Phillips RR, Lee MY, Berman HA, Madoff MA; The Tufts partnership for managed care education.; Acad Med; 1997 May; 72(5); 347-356
Hosea NA, Radic Z, Tsigelny I, Berman HA, Quinn DM, Taylor P; Aspartate 74 as a primary determinant in acetylcholinesterase governing specificity to cationic organophosphonates.; Biochemistry; 1996 Aug; 35(33); 10995-11004
Taylor P, Radic Z, Hosea NA, Camp S, Marchot P, Berman HA; Structural bases for the specificity of cholinesterase catalysis and inhibition.; Toxicol Lett; 1995 Dec; 82-83; 453-458
Hosea NA, Berman HA, Taylor P; Specificity and orientation of trigonal carboxyl esters and tetrahedral alkylphosphonyl esters in cholinesterases.; Biochemistry; 1995 Sep; 34(36); 11528-11536
Weis EI, Berman HA, Mesches DN; The equity model: three commentaries.; J Ambulatory Care Manage; 1994 Oct; 17(4); 77-81
Berman HA, Leonard K; Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.; Mol Pharmacol; 1992 Feb; 41(2); 412-418
Jo SA, Higgins DM, Berman HA; Regulation of acetylcholinesterase in avian heart. Studies on ontogeny and the influence of vagotomy.; Circ Res; 1992; 70; 633-643
Nowak MW, Berman HA; Fluorescence studies on the interactions of myelin basic protein in electrolyte solutions.; Biochemistry; 1991 Jul; 30(30); 7642-7651
Berman HA, Leonard K; Ligand exclusion on acetylcholinesterase.; Biochemistry; 1990 Nov; 29(47); 10640-10649
Decker MM, Berman HA; Denervation-induced alterations of acetylcholinesterase in denervated and nondenervated muscle.; Exp Neurol; 1990 Aug; 109(2); 247-255
Decker MM, Berman HA; Dihydropyridine receptor regulation of acetylcholinesterase biosynthesis.; J Biol Chem; 1990 Jul; 265(20); 11796-11803
Conti CR, Williams JF, Anderson JL, Berman HA, Gunnar RM, Herman GP, Lyons FW, Passamani ER, Reid PR, Silverman ME; Ethics in cardiovascular medicine. Task Force V: The relation of cardiovascular specialists to industry, institutions and organizations.; J Am Coll Cardiol; 1990 Jul; 16(1); 30-33
Berman HA, Decker MM; Chiral nature of covalent methylphosphonyl conjugates of acetylcholinesterase.; J Biol Chem; 1989 Mar; 264(7); 3951-3956
Berman HA, Leonard K; Chiral reactions of acetylcholinesterase probed with enantiomeric methylphosphonothioates. Noncovalent determinants of enzyme chirality.; J Biol Chem; 1989 Mar; 264(7); 3942-3950
Johnson DA, Brown RD, Herz JM, Berman HA, Andreasen GL, Taylor P; Decidium. A novel fluorescent probe of the agonist/antagonist and noncompetitive inhibitor sites on the nicotinic acetylcholine receptor.; J Biol Chem; 1987 Oct; 262(29); 14022-14029
Berman HA, Decker MM, Nowak MW, Leonard KJ, McCauley M, Baker WM, Taylor P; Site selectivity of fluorescent bisquaternary phenanthridinium ligands for acetylcholinesterase.; Mol Pharmacol; 1987 Jun; 31(6); 610-616
Berman HA, Decker MM, Jo S; Reciprocal regulation of acetylcholinesterase and butyrylcholinesterase in mammalian skeletal muscle.; Dev Biol; 1987 Mar; 120(1); 154-161
Edery H, Geyer MA, Taylor P, Berman HA; Target sites for anticholinesterases on the ventral surface of the medulla oblongata: hypotension elicited by organophosphorus agents.; J Auton Pharmacol; 1986 Sep; 6(3); 195-205
Berman HA, Decker MM; Kinetic, equilibrium, and spectroscopic studies on dealkylation ('aging') of alkyl organophosphonyl acetylcholinesterase. Electrostatic control of enzyme topography.; J Biol Chem; 1986 Aug; 261(23); 10646-10652
Berman HA, Decker MM; Kinetic, equilibrium and spectroscopic studies on cation association at the active center of acetylcholinesterase: topographic distinction between trimethyl and trimethylammonium sites.; Biochim Biophys Acta; 1986 Jul; 872(1-2); 125-133
Berman HA, Yguerabide J, Taylor P; Flexibility of the molecular forms of acetylcholinesterase measured with steady-state and time-correlated fluorescence polarization spectroscopy.; Biochemistry; 1985 Dec; 24(25); 7140-7147
Edery H, Berman HA; Yohimbine antagonism of the vasodepression elicited by organophosphates applied on ventral medulla oblongata.; J Auton Nerv Syst; 1985 Nov; 14(3); 229-238
Berman HA, Olshefski DF, Gilbert M, Decker MM; Fluorescent phosphonate labels for serine hydrolases. Kinetic and spectroscopic properties of (7-nitrobenz-2-oxa-1,3-diazole)aminoalkyl methylphosphonofluoridates and their conjugates with acetylcholinesterase molecular forms.; J Biol Chem; 1985 Mar; 260(6); 3462-3468
Zheng S, Berman HA, Geyer MA; Behavior during hippocampal microinfusions: anticholinesterase-induced locomotor activation.; Behav Brain Res; 1983 Sep; 9(3); 295-304
Berman HA, Becktel W, Taylor P; Spectroscopic studies on acetylcholinesterase: influence of peripheral-site occupation on active-center conformation.; Biochemistry; 1981 Aug; 20(16); 4803-4810
Berman HA, Yguerabide J, Taylor P; Fluorescence energy transfer on acetylcholinesterase: spatial relationship between peripheral site and active center.; Biochemistry; 1980 May; 19(10); 2226-2235
Epstein DJ, Berman HA, Taylor P; Ligand-induced conformational changes in acetylcholinesterase investigated with fluorescent phosphonates.; Biochemistry; 1979 Oct; 18(21); 4749-4754
Berman HA, Taylor P; Fluorescent phosphonate label for serine hydrolases, pyrenebutyl methylphosphonofluoridate: reaction with acetylcholinesterase.; Biochemistry; 1978 May; 17(9); 1704-1713
Berman HA, Barza M, Weinstein L; Serum sulfonamide concentration after oral administration: comparison of results of chemical assay with two bioassay techniques.; Antimicrob Agents Chemother; 1972 Mar; 1(3); 268-273
Berman HA, Weinstein L; Antibiotics and nutrition.; Am J Clin Nutr; 1971 Feb; 24(2); 260-264
Berman HA, Weinstein L; Search for trichinella infection in Western Samoa and Fiji.; Med J Aust; 1970 Sep; 2(13); 583-584
Grossman W, Berman HA; Typhoid fever in the previously immunised.; Lancet; 1968 Oct; 2(7573); 867-868
Klocke RA, Augerson WS, Berman HH, Burgos FL, Rivera RA; Desquamative interstitial pneumonia. A disease with a wide clinical spectrum.; Ann Intern Med; 1967 Mar; 66(3); 498-506
Taylor P, Hosea NA, Tsigelny I, Radic Z, Berman HA; Determining ligand orientation and transphosphonylation mechanisms on acetylcholinesterase by Rp, Sp enantiomer selectivity and site-specific mutagenesis.; Enantiomer; 2(3-4); 249-260
Berman HA; Physicians must share in costs, savings.; Internist; 26(5); 17-17



 
Dr. Harvey Berman
Dr. Harvey Berman